Bharat Biotech
News and Video Search Results
News coverage
-
Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study
IndiaTimes
-
Over 30% Covaxin takers suffered from health issues after 1 year: Report
IndiaTimes
-
Global Human Vaccines Business Report 2024-2030 - Combination Vaccines Market Driven by Fast Expanding Pediatric Population
GlobeNewswire
-
Global $94B+ Vaccines Market Outlook, 2024-2030 by Type, Technology, Indication, Route of Administration, Age Group and Region - Rising Need for DPT Vaccine for Protection Against Serious Respiratory Ailments
GlobeNewswire
0 shares
1 views
You might like
Bharat Biotech media coverage
Time to leverage Intellectual Property to Drive Innovation and Competitiveness for Viksit Bharat: Seed Industry
NewsVoir
Indias agricultural sector is undergoing a remarkable transformation, embracing innovation and technology at an accelerated pace...
-
Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects
IndiaTimes
-
'Safety first', says Bharat Biotech amid AstraZeneca row
IndiaTimes
-
Global COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine Production
GlobeNewswire
-
RSV Vaccine Market To Reach USD 2.2 Billion By 2032 | DataHorizzon Research
GlobeNewswire
Advertisement
More coverage
-
Global Human Vaccines Market (2023-2028)
GlobeNewswire
-
Bharat Biotech begins clinical trials of more effective TB vaccine in India
IndiaTimes
-
Bharat Biotech begins clinical trials of TB vaccine on adults in India
IndiaTimes
-
Asia Pacific Preventive Vaccines Market to Hit Valuation of USD 63.11 Billion by 2032: Astute Analytica
GlobeNewswire